EMA invites feedback on how advanced therapy medicinal products are classified
This article was originally published in Clinica
Executive Summary
The European Medicines Agency’s Committee for Advanced Therapies has just issued for public consultation an update of a reflection paper on the classification of advanced-therapy medicinal products (ATMPs).